Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
|
|
- Justin Wilkinson
- 5 years ago
- Views:
Transcription
1 Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary
2 Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical Trials Support, Allergan and Amgen Speakers Bureau/Honoraria: Allergan, Amgen, Serono. Consulting Fees: Allergan, Amgen Other: None
3 What is Migraine? Migraine is an inherited, disabling neurological condition that leads to attacks of head pain, sensitivity to the environment, and other neurological symptoms. Migraine is a genetic condition, but many factors over a person s lifetime affect how frequent and severe migraine can be.
4 Overall, the one year point prevalence of migraine is 12 % in the adult general population 4
5 Prevalence of Chronic Migraine in the United States Chronic migraine accounts for 8 % of all migraine cases, 1 % of the general population Schwedt TJ BMJ 2014; 348: g1416
6 Diagnosis and Management of Chronic Migraine is Complex Chronic migraine must be differentiated from secondary headaches causing frequent or daily headache There is often no single simple solution to the pain and disability faced by patients Many patients will need: 1. Lifestyle and trigger advice 2. Behavioural management (e.g. stress management skills, relaxation skills etc.) 3. Acute pharmacological treatment 4. Prophylactic pharmacological treatment 5. Management of acute medication overuse
7 Diagnosis
8 8 Headache Case A 30 year old female has a history of unilateral headaches starting at age 20 that throbbed, lasted 36 hours untreated, and had significant associated nausea. For two years she has had headache on about 23 days a month. These are often bilateral and of moderate severity. On about 12 days a month she has more severe unilateral throbbing headache. She is taking sumatriptan on at least 12 days a month, and acetaminophen with codeine on 8 additional days a month.
9 9 Case 2. Her headache disorder is most correctly classified as: a. b. c. d. e. Medication overuse headache Chronic migraine Chronic tension-type headache Both chronic migraine and medication overuse headache Mixed headache with both migraine and tension-type headache
10 Diagnostic Criteria
11 11 Criteria for Chronic Migraine A. Headache (tension-type and / or migraine) on 15 days per month for at least 3 months. B. Has had at least 5 attacks of migraine with or without aura. C. On 8days per month for 3 months has fulfilled criteria for migraine, or was believed to be migraine and treated successfully with a triptan or ergot. D. Not better accounted for by another diagnosis. ICHD-3 Cephalalgia 2013; 33(9):
12 12 Migraine Without Aura At least 5 attacks with: 4-72 hour duration 2 of: unilateral location pulsating pain moderate or severe intensity aggravation by or causing avoidance of physical activity during attack 1 of: nausea and/or vomiting photo and phonophobia No other cause apparent ICHD-3Cephalalgia 2013; 33(9):
13 How is Chronic Migraine defined in ICHD-3 beta? Changes from ICHD-2 Chronic Migraine diagnosis excludes chronic tension-type headache diagnosis 8 migraine days a month may be with or without aura Patients who meet criteria for both Chronic Migraine and medication-overuse headache should be diagnosed with both Headache Classification Committee of the International Headache Society (IHS). Cephalalgia. 2013;33:
14 Diagnostic Algorithm for Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):
15
16 Diagnostic Algorithm for Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):
17 Management of Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):
18 Becker WJ, Headache 2017 Oct;57(9):
19 Becker WJ, Headache 2017 Oct;57(9):
20 The Headache Diary Record days with headache and headache intensity Record acute medication use, and the response to these medications Record prophylactic medication use Keep a record of occurrence of potential triggers Record menstrual cycle
21 Management of Medication Overuse Headache Becker WJ, Headache 2017 Oct;57(9):
22 Case 1: 58 year old male Migraine since 12 years of age Chronic daily headache for at least ten years prior to being seen, associated with daily use of acetaminophen and ibuprofen On amitriptyline 25 mg daily What is the single most important management strategy at this point?
23 Provide information of necessary limits to avoid risk of medication overuse headache: -Use of triptans and combination analgesics on < 10 days a month -Use of acetaminophen or NSAIDs on < 15 days a month or more.
24 Medication Overuse Headache: Headache days per month: Brief advice intervention versus usual care Intervention: Information and advice to stop medication overuse by primary care physician Double-blind Randomized Controlled Trial Mean duration of Medication overuse: 8 years Baseline: dotted lines; 3 month follow up: solid lines
25 Medication Overuse Headache Medication days: Brief advice intervention vs usual care Intervention: Information And advice to stop medication Overuse by primary care physician Double-blind Randomized Controlled Trial Mean duration of Medication overuse: 8 years Baseline: dotted lines; 3 month follow up: solid lines
26 Management of Medication Overuse Headache (Continued)
27 Systematic Review of Medication Overuse Headache: Conclusions Adding preventive medications to early discontinuation of overused medications leads to a better outcome than early discontinuation alone. Preventive medications alone may have some utility in medication overuse headache Chiang C-C, et al Cephalalgia 2016; 36(4):
28 Standard of Care Standard of Care for patients with chronic migraine and medication overuse headache: 1. Stop overused medication, but combine with: - Preventive medications and / or biobehavioural therapy Chiang C-C, et al Cephalalgia 2016; 36(4):
29 Treatment of medication overuse headache Patient education Stop medication overuse Start prophylactic Treat severe attacks Patient follow-up 29
30 Management of Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):
31 Prescribing a Migraine Preventive Medication Educate the patient that the medication must be taken daily Ensure the patient has realistic expectations of benefit: 1. Headache attacks will not be abolished completely 2. A reduction of headache frequency of 50% is considered worthwhile 3. In chronic migraine, even lesser reductions in frequency, or reductions in intensity may make prophylaxis worth while. 4. It may take 4 to 8 weeks for significant benefit to occur, and this may increase with time Increase the dose until the medication is effective, dose limiting side effects occur, or a target dose is reached Becker WJ, Headache 2017 Oct;57(9):
32 Schwedt TJ BMJ 2014; 348: g1416 *Other drugs With evidence fo Efficacy in Episodic migraine Are also used clinically
33 Motto: Start Low and go Slow Becker WJ, Headache 2017 Oct;57(9):
34 Management of Chronic Migraine (Continued) Becker WJ, Headache 2017 Oct;57(9):
35
36
37 Use of OnabotulinumtoxinA in Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):
38 OnabotulinumtoxinA mode of action OnabotulinumtoxinA blocks release of glutamate and peptides from nociceptive nerve endings. Sensory neurons not only take up local onabot, but moves it via fast axonal transport to their central terminals. Onabot may regulate cell surface expression of a number of receptors and ion channels (TRPV1, AMPA, etc). Some (many) nociceptive nerve fibers have branches both on the meninges and in the extracranial structures. Ramachandran R et al B J Pharmacol 2014; 171:
39 Roles of Primary Care Provider In Chronic Migraine Becker WJ, Headache 2017 Oct;57(9):
40 Referral of the Chronic Migraine Patient By the Primary Care Provider And Role After Referral Becker WJ, Headache 2017 Oct;57(9):
41 Factors associated with reversion of Chronic migraine to episodic migraine 1. Lower baseline headache frequency (15 19 vs days per month) 2. Adherence to prophylactic drugs 3. Withdrawal of overused acute drugs 4. Physical exercise 5. Correction of sleep disturbances (Calhoun AH Headache Sep;47(8): )
42 The Diagnosis and Management of Chronic Migraine in Primary Care The primary care physician is critical in identifying patients with chronic migraine and initiating therapy. Initiation of therapy should include both pharmacological and nonpharmacological approaches. In Canada, the availability of medical resources and the high prevalence of chronic migraine dictates that the role of the primary care physician must be significant in order to help patients with chronic migraine
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches
Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, 2016 II. Management of Refractory Headaches Case presentation 1: A case of intractable daily-persistent headache Keio University School
More informationHow do we treat migraine? New SIGN Guidelines
How do we treat migraine? New SIGN Guidelines Managing your migraine Migraine Trust, Edinburgh 2018 Callum Duncan Consultant Neurologist Aberdeen Royal Infirmary Chair SIGN Guideline 155 Premonitory Mood
More informationUnderstanding. Migraine. Amy, diagnosed in 1989, with her family.
Understanding Migraine Amy, diagnosed in 1989, with her family. What Is a Migraine? A migraine is a recurring moderate to severe headache. The pain usually occurs on one side of the head. It is typically
More informationI have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.
I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation. In 1962, Bille published landmark epidemiologic survey of headache among 9,000 school
More informationA case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:
Chronic Daily Headache Bassel F. Shneker, MD, MBA Associate Professor Vice Chair, OSU Neurology The Ohio State University Wexner Medical Center Financial Disclosures None related to the presentation Grants
More informationJessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital
Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital Honorarium from Current Pain and Headache Reports; Section Editor Unusual
More information10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY
BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES JENNIFER SHIN, PHARMD PGY2 AMBULATORY CARE PHARMACY RESIDENT COMMUNITYCARE HEALTH CENTERS PHARMACOTHERAPY ROUNDS OCTOBER 20, 2017
More informationFaculty Disclosures. Learning Objectives. Acute Treatment Strategies
WWW.AMERICANHEADACHESOCIETY.ORG Acute Treatment Strategies Content developed by: Lawrence C. Newman, MD, FAHS Donna Gutterman, PharmD Faculty Disclosures LAWRENCE C. NEWMAN, MD, FAHS Dr. Newman has received
More informationCurrent Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN
Current Migraine Treatment Therapy Daniel Kassicieh, DO, FAAN Migraine a Disease Process Migraines are a chronic disease process similar to many other chronic medical conditions Migraine has a low mortality
More informationDifferentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD
Differentiating Migraine from Other Headache Types to Target Treatment Peter J. Goadsby, MD, PhD University of California, San Francisco San Francisco, CA King's College London London, England Learning
More informationปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา
ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา 1 CONTENT 1 2 3 Chronic Daily Headache Medical Overused Headache Management Headaches are one of the most common symptoms List
More informationMigraine much more than just a headache
Migraine much more than just a headache Session hosted by Teva UK Limited PUU4 11:15 12:15 UK/NHSS/18/0021b Date of Preparation: August 2018 The views expressed in this presentation are those of the speaker
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest
More informationPaediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition
Paediatric headaches Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services Brevity, levity, repetition Paediatric)headache?)! Headache!in!children!is!not!that!common.!The!question!is!which!headaches!do!I!
More informationIshaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert
Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert Childhood headache: Is it really difficult to manage? It shouldn t be... But it can be...
More informationHEADACHE: Benign or Severe Dr Gobinda Chandra Roy
HEADACHE: Benign or Severe Dr Gobinda Chandra Roy Associate Professor, Department of Medicine, Shaheed Suhrawardy Medical College and Hospital Outlines 1. Introduction 2. Classification of headache 3.
More informationMIGRAINE A MYSTERY HEADACHE
MIGRAINE A MYSTERY HEADACHE The migraine is a chronic neurological disease that is characterized by moderate to severe episodes of headache that is mostly associated with other central nervous system (CNS)
More informationManagement of headache
Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener,
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationFaculty/Presenter Disclosure
Headache Pathway Overview How can I help my migraine patient? Dr Elizabeth Leroux, MD, FRCPC Headache Program University of Calgary Banff 2018 Faculty/Presenter Disclosure Faculty/Presenter: Dr. Elizabeth
More informationSpecific Objectives A. Topics to be lectured and discussed at the plenary sessions
Specific Objectives A. Topics to be lectured and discussed at the plenary sessions 0. Introduction: Good morning ICHD-III! Let s start at the very beginning. When you read you begin with A-B-C, so when
More informationOutpatient Headache Care Guideline
1 Outpatient Care Guideline Inclusion criteria: children > 3 yrs with headaches Is urgent emergency department, neuroimaging, or Neurology consultation indicated? Referral to ED if: New severe headache
More informationProposed Project Scope. OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice
Proposed Project Scope OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice May 2018 1. BACKGROUND AND RATIONALE Migraine is a common, debilitating
More informationUpdate on Diagnosis and Management of Migraines
Update on Diagnosis and Management of Migraines Joel J. Heidelbaugh, MD, FAAFP, FACG Clinical Professor Departments of Family Medicine and Urology University of Michigan Learning Objectives To distinguish
More informationDisclosures. Objectives 6/2/2017
Classification: Migraine and Trigeminal Autonomic Cephalalgias Lauren Doyle Strauss, DO, FAHS Assistant Professor, Child Neurology Assistant Director, Child Neurology Residency @StraussHeadache No disclosures
More informationClinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.
OVERVIEW Refractory headaches and update on novel treatment Definition of refractory headache Treatment approach Medications Neuromodulation In the pipeline Juliette Preston, MD OHSU Headache Center Refractory
More informationUCNS Course A Review of ICHD-3b
UCNS Course A Review of ICHD-3b Andrew D. Hershey, M.D., Ph.D., FAHS Endowed Chair and Director of Neurology Director, Cincinnati Children s Headache Center Professor of Neurology and Pediatrics University
More informationÇiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE
Headache in children and adolescents Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE Dept. of Psychiatry of Childhood and Adolescence Medical University of Vienna, Vienna, Austria Impact
More informationWhat is the Effectiveness of OnabotulinumtoxinA (Botox ) in Reducing the Number of Chronic Migraines (CM) in Patients Years Old?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2013 What is the Effectiveness of OnabotulinumtoxinA
More informationHeadaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)
Headaches. Mini Medical School. November 10, 2016 A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology) Artist Agnes Cecile Disclosures I have received an honorarium from
More informationMigraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital
Migraine Management Jane Melling Headache nurse Mater Misericordiae Hospital Migraine facts Among the most common disorders of the nervous system 3 rd most prevalent medical disorder on the planet (lancet
More informationHeadache Pain Generators
Objectives 1. Define the major categories of headache. 2. Take a history directed at characterizing a headache pattern in an individual patient and identify the cause or triggers of the headache. 3. Understand
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 8 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationDubai Standards of Care (Migraine)
Dubai Standards of Care 2018 (Migraine) Preface Migraine is one of the most common problem dealt with in daily practice. In Dubai, the management of migraine is done through various different strategies.
More informationPainless, progressive weakness Could this be Motor Neurone Disease?
APPENDIX 1 Painless, progressive weakness Could this be Motor Neurone Disease? 1. Does the patient have one or more of these? Bulbar features Limb features Respiratory features Cognitive features (rare)
More informationMEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache
MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache Measure Description Percentage of patients age 18 years old and older diagnosed with migraine headache whose migraine frequency is 4 migraine
More informationDavid W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA
Headache Masters School 2013 in Asia Sunday March 24, 2013 Procedural Medicine Workshop Onabotulinumtoxin A: Evidence, Injection Technique, and Mechanism of Action David W. Dodick M.D. Professor Director
More informationStrategies in Migraine Care
Strategies in Migraine Care Julie L. Roth, MD Rhode Island Hospital Assistant Professor, Neurology The Warren Alpert Medical School of Brown University March 28, 2015 Financial Disclosures None. Objectives
More informationCase Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches
Agenda Case presentation Migraine Morphology Primary and Premonitory Phase Secondary Headache Aura Headache Primer on Pain Medication Overuse Headache Case Presentation RT is a 25 year old woman with daily
More informationA Q&A with N1-Headache users
A Q&A with N1-Headache users Content Guide: 1. Daily Factor logging 2 2. Migraine & Other Headaches 3 3. Medication & Medication Overuse 3-4 4. MAPS 5 2019 Curelator, Inc. All rights reserved. No part
More informationDaniel Kassicieh, DO, FAAN
Daniel Kassicieh, DO, FAAN Migraine a Disease Process Migraine is a chronic disease process similar to many other chronic medical conditions Migraine has a low mortality but high morbidity 38 million Americans
More informationMark W. Green, MD, FAAN
Mark W. Green, MD, FAAN Professor of Neurology, Anesthesiology, and Rehabilitation Medicine Director of Headache and Pain Medicine Icahn School of Medicine at Mt Sinai New York Pain-sensitive structures
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More informationA synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN
A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline Scottish intercollegiate Guidelines Network SIGN November 2008. PETER FRAMPTON MSc MCOptom BAppSc (Optom)(AUS)
More informationRisk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute
Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics Rebecca R. Buttaccio, PA-C Dent Neurologic Institute Speaker for Avanir Disclosures Learning Objectives 1. Review the risk factors
More informationRegulatory Status FDA approved indication: Migranal Nasal Spray is indicated for the acute treatment of migraine headaches with or without aura (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: November 30, 2018 Migranal Nasal Spray
More informationMigraine Types and Triggering Factors in Children
original ARTICLE Migraine Types and Triggering Factors in Children How to Cite this Article: Nejad Biglari H, Karimzadeh P, Mohammadi Kord-kheyli M, Hashemi SM. Migraine Types and Triggering Factors in
More informationAleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia
European Headache School Belgrade 2012 MEDICATION OVERUSE HEADACHE Aleksandra Radojičić Headache Center, Neurology Clinic, Clinical Center of Serbia Historical data First cases were described in XVII century
More informationPHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
ALLZITAL (butalbital and acetaminophen) 25 mg/325 mg oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More informationStuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth
Stuart Weatherby Consultant Neurologist Derriford Hospital. Plymouth What is chronic headache? What are the causes? Why do people get headaches anyway? Why are there different sorts of headache? A model
More informationThis policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.
RimabotulinumtoxinB NDC CODE(S) 10454-0710-XX Myobloc 2500 UNIT/0.5ML SOLN (SOLSTICE NEUROSCIENCES) 10454-0711-XX Myobloc 5000 UNIT/ML SOLN (SOLSTICE NEUROSCIENCES) 10454-0712-XX Myobloc 10000 UNIT/2ML
More informationWhat You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself
What You Should Know About Your HEADACHE Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself Introduction The purpose of this brochure is to give you a
More informationHEADACHE. Dr Nick Pendleton. September Headache
HEADACHE Dr Nick Pendleton September 2017 Headache Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache Raised ICP
More information25/09/2018 HEADACHE. Dr Nick Pendleton
HEADACHE Dr Nick Pendleton September 2018 1 Small Group Work Tension Type Headache Cranial Nerve Examination Migraine Migraine Treatment Medication Overuse Headache Headache Red Flags Sinusitis Headache
More informationManagement options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM
Management options for Migraine Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM Assessment The Migraine Disability Assessment Score MIDAS Complete loss of work Partial loss of work Off
More informationHeadache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology
Headache and Facial Pain Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology Introduction It is the most common neurologic complain The diagnosis usually
More informationPrednisone vs. placebo in withdrawal therapy following medication overuse headache
doi:10.1111/j.1468-2982.2007.01488.x Prednisone vs. placebo in withdrawal therapy following medication overuse headache L Pageler 1,2, Z Katsarava 2, HC Diener 2 & V Limmroth 1,2 1 Department of Neurology,
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
CGRP Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: CGRP (calcitonin gene-related peptide) Prime Therapeutics will review Prior Authorization requests
More informationPrevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.
Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D. Objectives Present patient case Review epidemiology/pathophysiology
More informationRecognition and treatment of medication overuse headache
Recognition and treatment of medication overuse headache Marcus Lewis MA, MRCGP, DRCOG, DFSRH 20 Mean weekly headache index 15 10 5 Medication overuse headache is a common condition responsible for a high
More informationDisclosures. Triptans for Kids 5/16/13
5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS
More informationUNDERSTANDING CHRONIC MIGRAINE. Learn about diagnosis, management, and treatment options for this headache condition
UNDERSTANDING CHRONIC MIGRAINE Learn about diagnosis, management, and treatment options for this headache condition 1 What We re Going to Cover Today The symptoms and phases of migraine Differences between
More information10/19/2018. Disclosures MIGRAINE PROPHYLAXIS. Objectives. Definitions Slide. What do you think the aooe stands for at the end of erenumab-aooe?
Disclosures MIGRAINE PROPHYLAXIS Erenumab-aooe (AIMOVIG TM ) Calcitonin Gene Related Peptide Receptor Antagonist No conflicts of interest to disclose Chelsey Roscoe, PharmD PGY1 Resident - CTVHCS 2 3 Definitions
More informationMIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.
MIGRAINE UPDATE Karen L. Bremer, MD November 16, 2018 Objectives & Disclosures Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment. Disclosure: I am
More informationOH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES
1 JUSTIN A. OSSMAN, MD CHATTANOOGA FAMILY MEDICINE UPDATE OH, MY ACHING HEAD! MANAGING HEADACHE IN THE OUTPATIENT SETTING 2 I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE OBJECTIVES International
More informationOveruse of barbiturate and opioid containing medications for primary headache disorders Description
Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed
More information10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD
Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD } Depomed Consultant 2014 to present } Avanir Consultant 2014 to present } Amgen
More informationIs Yoga an Effective Treatment for Reducing the Frequency of Episodic Migraine?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2018 Is Yoga an Effective Treatment for Reducing
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationIs Topiramate Effective in Preventing Pediatric Migraines?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2013 Is Topiramate Effective in Preventing
More informationHEADACHE: Types, Tips & Treatment Suggestions
Headaches are one of the most common complaints patients present with in primary care settings. They are often correlated with stress, tension and a litany of existing medical conditions. Often, patients
More informationMigraine: Developing Drugs for Acute Treatment Guidance for Industry
Migraine: Developing Drugs for Acute Treatment Guidance for Industry U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) February 2018
More informationHeadache. Karen Thaxter
Headache Karen Thaxter An eight year old girl is taken to her paediatrician because she has been complaining of almost daily pain at the back of her head for the past 4 months. She states that each headache
More informationMaternity. Migraine in pregnancy Information for women
Maternity Migraine in pregnancy Information for women You have been given this leaflet as you have a diagnosis of migraines. It contains advice to help you manage your migraines safely during your pregnancy.
More informationHeadaches in Pregnancy Before, During, and After
Headaches in Pregnancy Before, During, and After Robert Kaniecki, MD Director, UPMC Headache Center Assistant Professor of Neurology University of Pittsburgh Headaches and Pregnancy Pre-pregnancy counseling
More informationBy Nathan Hall Associate Editor
By Nathan Hall Associate Editor 34 Practical Neurology March 2005 These new rules may change the definition of head pain, but some practitioners may find the new guidelines themselves to be a source of
More informationJuly 2012 Target Population. Adult patients 18 years or older in primary care settings.
Guideline for Primary Care Management of Headache in Adults July 2012 Target Population Adult patients 18 years or older in primary care settings. Exclusions: This guideline does not provide recommendations
More informationIndex. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.
Prim Care Clin Office Pract 31 (2004) 441 447 Index Note: Page numbers of article titles are in boldface type. A Abscess, brain, headache in, 388 Acetaminophen for migraine, 406 407 headache from, 369
More informationMigraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital
Migraine Management Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital Referral Criteria for Migraine Migraine Management Migraine Diagnosis Spot on Health Migraine pathway
More information11/10/2017. THE BRIDGE Course Objectives. THE BRIDGE Course Objectives
THE BRIDGE Course Objectives Describe clinical characteristics associated with migraine diagnosis in adult and pediatric populations. Identify barriers and risk factors impacting the clinical course of
More informationMigranal Nasal Spray. Migranal Nasal Spray (dihydroergotamine) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.60 Subject: Migranal Nasal Spray Page: 1 of 5 Last Review Date: June 22, 2017 Migranal Nasal Spray
More informationCOMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS
ACUTE THEAPIES TIPTANS TICYCLIC ANTIDEPESSANTS When starting acute treatment, healthcare professionals should warn patients about the risk of developing medication-overuse headache. ASPIIN Aspirin (900
More informationONZETRA XSAIL (sumatriptan) nasal powder
ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationAdult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention
Adult with headache Problem-specific video guides to diagnosing patients and helping them with management and prevention London Strategic Clinical Networks London Neuroscience Strategic Clinical Network
More informationMigraine Management. Roger Cady, MD Headache Care Center Springfield, MO
Migraine Management Roger Cady, MD Headache Care Center Springfield, MO Disclosures Objectives The evolution of migraine From benign episodic (benign) headache to potentially a devastating chronic disease
More informationChronic Daily Headaches
Chronic Daily Headaches ANWARUL HAQ, MD, MRCP(UK), FAHS DIRECTOR BAYLOR HEADACHE CENTER, DALLAS, TEXAS DISCLOSURES: None OBJECTIVES AT THE CONCLUSION OF THIS ACTIVITY, PARTICIPANTS WILL BE ABLE TO: define
More informationManaging Headache in Acute Medicine. Ben Lovell Consultant Physician in Acute Medicine University College London Hospital
Managing Headache in Acute Medicine Ben Lovell Consultant Physician in Acute Medicine University College London Hospital Some ED headache stats Arrive by ambulance 31% Median age 39 Worst ever headache
More information6/2/2017. Objectives. Statement of Problem: Migraine Headaches Are Common. Chronic Headache In Pediatrics, Botox and Beyond
Chronic Headache In Pediatrics, Botox and Beyond Ken Mack MD PhD Mayo Clinic 2015 MFMER slide-1 Objectives Understand pediatric chronic headache presentations Review evidence for the treatment of chronic
More informationSubject: CGRP Inhibitors
ARCHIVED (NOT ACTIVE RETIRED) Archived: 08/01/18 09-J2000-98 Original Effective Date: 06/15/18 Reviewed: 05/09/18 Revised: 08/01/18 Next Review: ARCHIVED (NOT ACTIVE RETIRED) Subject: CGRP Inhibitors THIS
More informationMigraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin 12/09/2015
1 Migraine: Past, Present and Future Edward O Sullivan September 12 th 2015 Dublin Tour de France 2015: Mark Renshaw Yesterday at the end of the stage 17 I came down with a migraine before the final climb
More informationMigraine and hormonal contraceptives
Migraine and hormonal contraceptives Department of Community Medicine, Systems Epidemiology University of Tromsø, November 2017 Nora Stensland Bugge Medical research student Presentation outline What is
More informationWHY IS MIGRAINE IMPORTANT
WHY IS MIGRAINE IMPORTANT Migraine is a complex disorder characterized by recurrent episodes of headache, most often unilateral and in some cases associated with visual or sensory symptoms collectively
More informationMigraine Treatment What you need to know
Migraine Treatment What you need to know DR NICOLE LIMBERG ST ANDREWS PLACE SPRING HILL www.migrainespecialist.com.au Migraine what is it? Primary neurobiological condition Waves of reduced brain activity
More informationNEXT GENERATION MIGRAINE THERAPIES. Saturday, April 6, 2019 Sheraton San Diego Hotel & Marina-Bay Tower San Diego, California
Saturday, April 6, 2019 Sheraton San Diego Hotel & Marina-Bay Tower San Diego, California Saturday, May 18, 2019 Westin Galleria Dallas Dallas, Texas Saturday, June 8, 2019 Marriott Marquis New York New
More informationGet ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention
Get ahead of the ACHE: Monoclonal Antibodies in Migraine Prevention Amanda Janisch, PharmD PGY2 Ambulatory Care Pharmacy Resident MCHS SWMN, Mankato, MN 2018 MFMER slide-1 Disclosures No financial interest
More informationSubject: Aimovig (erenumab) Original Effective Date: 7/10/2018. Policy Number: MCP-320. Revision Date(s):
Subject: Aimovig (erenumab) Original Effective Date: 7/10/2018 Policy Number: MCP-320 Revision Date(s): Review Date(s): MCPC Approval Date: 7/10/2018 DISCLAIMER This Molina Clinical Policy (MCP) is intended
More informationTreatment Of Medication. Overuse Headache
7 November 2012 BASH GPwSI Meeting Lecture title... Treatment Of Medication Dr... Overuse Headache Dr Marcus Lewis Dr... The National Migraine Centre International Headache Society Diagnostic criteria
More informationMigraine By Oliver Sacks READ ONLINE
Migraine By Oliver Sacks READ ONLINE Migraine definition, an extremely severe paroxysmal headache, usually confined to one side of the head and often associated with nausea; hemicrania. See more. More
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: surgical_deactivation_of_migraine_headache_trigger_sites 10/2012 5/2017 5/2018 5/2017 Description of Procedure
More information